Insulin Resistance Syndrome Type B C0342337
A metabolic disorder marked by severe resistance to insulin, where the body cannot respond to this hormone properly. Often linked to autoimmune issues and causes elevated blood sugar. Treatment involves insulin-sensitizing medications and blood sugar management.
Key facts at a glance
- ICD-10
- E34.9
- ICD-11
- 5A00.0
- Body system
- endocrine
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Fatigue or weight changes
(endocrine)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Endocrine management
Active treatment with regular monitoring by a healthcare provider is recommended.
Insulin-sensitizing agents
Metformin and related agents improve insulin sensitivity at tissue level, addressing the underlying insulin resistance characteristic of this syndrome. First-line glucose management approach.
Immunosuppressive therapy
Given the autoimmune nature of insulin resistance syndrome type B, immunosuppressants such as rituximab or corticosteroids may be indicated to address underlying autoimmunity.
Additional treatment options
Medical nutrition therapy
Low glycemic index diet with controlled carbohydrate intake to minimize glucose spikes and reduce insulin requirements. Structured meal planning with emphasis on fiber and protein.
dietaryPhysical activity program
Regular exercise improves insulin sensitivity independent of weight loss. Structured aerobic and resistance training program tailored to individual capability.
lifestyleMetabolic parameter surveillance
Regular monitoring of HbA1c, fasting glucose, insulin levels, and lipid panel to assess treatment response and adjust therapy accordingly.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Insulin Resistance Syndrome Type B C0342337?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Insulin Resistance Syndrome Type B C0342337. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy